Common challenges, uncommon solutions
All of our programs are developed by first focusing on the problem, sometimes in partnership with large strategics, and then solving the problem in a non-obvious way together with a brilliant group of cross-disciplinary experts, unencumbered by the bounds of traditional drug development.
We concentrate on a handful of major initiative areas at a time, generate and review hundreds of technologies, and drive forward one to two programs a year.
Obesity is a global epidemic that effects more than half a billion adults worldwide, with obesity-associated medical costs exceeding $140 billion annually in the US alone ( WHO, CDC). To date, treatments have fallen short by failing to fully address the complexity of appetite regulation in a safe manner.
Pharmacological anti-obesity treatments typically modulate single targets and have been limited by toxicity and modest efficacy. Bariatric surgery and related devices, meanwhile, are highly invasive and recommended only for the most severe patients.
So, we asked“
What if you could swallow a capsule with safe non-caloric particles that would expand in your stomach to make you feel full?”
The result was Gelesis
A new approach to tackling obesity.